Therapeutic guidance
This page contains information on therapeutic guidance for inpatients and outpatients, and information on prescribing alerts.
Prescribing alerts
- ALERT Pioglitazone - August 2011
- ALERT Rosiglitazone Withdrawal Sept 2010
- ALERT Aspirin in Primary Prevention - May 2010
- ALERT Aspirin in Primary Prevention - April 2010
- ALERT Withdrawal of Sibutramine
- ALERT Glitazones Jan 2009
- ALERT Exenatide Aug 2008
- ALERT Rosiglitazone Feb 2008
- NICE Bites - Sept 2011
- Rimonabant MHRA Update July 2008
Outpatient therapeutic guidance
- Adolescence: Young people and diabetes
- Annual review - What is involved?
- Contraception, HRT and diabetes
- Defining diabetes
- Dietary management programme for people with diabetes
- Does the patient need insulin?
- Driving and diabetes
- Drugs for type 2 diabetes mellitus
- Employment and diabetes
- End-stages of life and the management of diabetes
- Foot ulcer and infection antibiotic guidelines
- Home blood glucose monitoring: Trafford policy
- How to diagnose diabetes
- Hypertension management
- Insulin pump therapy
- Interpretation of the oral glucose tolerance test?
- Microalbuminuria, Proteinuria and Renal Disease
- Monitoring diabetes advice for HCP's
- Neuropathy
- PCT guidance on management of type 2 diabetes mellitus
- Travel and diabetes
- Where to look for new cases of diabetes mellitus
Inpatient therapeutic guidance
- Children with new-onset diabetes
- Diabetic Ketoacidosis (DKA) Adults
- Diabetic Ketoacidosis (DKA) Children
- Digami regime
- Enteral feeding and diabetes
- Hyperosmolar Non Ketotic Acidosis (HONK)
- Insulin i.v. sliding scale
- Metformin and x-ray contrast materials
- Preparation for bronchoscopy
- Preparation for gastrointestinal investigations
- Preparation for surgery
